“…Fifteen species of the Anacardiaceae family were selected to be reviewed for their pharmacological effects on controlling the lipid profile of dyslipidemia. Those species are Anacardium occidentale [17][18][19][20][21], Buchanania lanzan Spreng [22], Lennea edulis [23], Mangifera indica [24][25][26][27][28], Pistacia atlantica [29], Pistacia khinjuk [30], Pistacia lentiscus [31][32][33], Pleiogynium timorense [34], Protorhus longifolia [35], Rhus coriaria [36][37][38][39][40], Rhus mysurensis Heyne [41], Rhus verniciflua [42], Schinus terebinthifolius [43], Semecarpus anacardium [44,45], and Spondias pinnata [46,47]. As those species are varied, their substances are different, leading to their variety of pharmacological effects.…”